{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:47:37Z","timestamp":1791571657462,"version":"4.3.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Current clinical guidelines recommend antifibrinolytic treatment for liver transplantation to reduce blood loss and transfusion utilization. However, the clinical relevance of fibrinolysis during liver transplantation is questionable, a benefit of tranexamic acid (TXA) in this context is not supported by sufficient evidence, and adverse effects are also conceivable. Therefore, we tested the hypothesis that use of TXA is associated with reduced blood loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study on patients who underwent liver transplantation between 2004 and 2017 at Heidelberg University Hospital, Heidelberg, Germany. Univariable and multivariable linear regression analyses were used to determine the association between TXA administration and the primary end point intraoperative blood loss and the secondary end point intra- and postoperative red blood cell (RBC) transfusions. For further secondary outcome analyses, the time to the first occurrence of a composite end point of hepatic artery thrombosis, portal vein thrombosis, and thrombosis of the inferior vena cava were analyzed using a univariable and multivariable Cox proportional hazards model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Data from 779 transplantations were included in the final analysis. The median intraoperative blood loss was 3000 mL (1600\u20135500 mL). Intraoperative TXA administration occurred in 262 patients (33.6%) with an average dose of 1.4 \u00b1 0.7 g and was not associated with intraoperative blood loss (regression coefficient B, \u22120.020 [\u22120.051 to 0.012],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .226) or any of the secondary end points (intraoperative RBC transfusion; regression coefficient B, 0.023 [\u22120.006 to 0.053],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .116), postoperative RBC transfusion (regression coefficient B, 0.007 [\u22120.032 to 0.046],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .717), and occurrence of thrombosis (hazard ratio [HR], 1.110 [0.903\u20131.365],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .321).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our data do not support the use of TXA during liver transplantation. Physicians should exercise caution and consider individual factors when deciding whether or not to administer TXA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006804","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T13:00:21Z","timestamp":1705582821000},"page":"598-608","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Tranexamic Acid Administration During Liver Transplantation Is Not Associated With Lower Blood Loss or With Reduced Utilization of Red Blood Cell Transfusion"],"prefix":"10.1213","volume":"139","author":[{"given":"Sarah","family":"Dehne","sequence":"first","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Riede","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Feisst","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Institute of Medical Biometry, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Klotz","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Departement of General, Visceral, and Transplantation Surgery, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Etheredge","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"H\u00f6lle","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Merle","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Internal Medicine IV (Gastroenterology, Infectious Diseases and Intoxications), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Departement of General, Visceral, and Transplantation Surgery, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W.","family":"Michalski","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Departement of General, Visceral, and Transplantation Surgery, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W.","family":"B\u00fcchler","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Departement of General, Visceral, and Transplantation Surgery, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Larmann","sequence":"additional","affiliation":[{"name":"Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"R1-20260317","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tmrv.2019.10.001","article-title":"Efficacy and safety of tranexamic acid in major non-cardiac surgeries at high risk for transfusion: a systematic review and meta-analysis.","volume":"34","author":"Houston","year":"2020","journal-title":"Transfus Med Rev"},{"key":"R2-20260317","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/lt.20868","article-title":"Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation.","volume":"12","author":"McCluskey","year":"2006","journal-title":"Liver Transpl"},{"key":"R3-20260317","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jss.2015.02.016","article-title":"Patterns of care among patients undergoing hepatic resection: a query of the National Surgical Quality Improvement Program-targeted hepatectomy database.","volume":"196","author":"Spolverato","year":"2015","journal-title":"J Surg Res"},{"key":"R4-20260317","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(11)61381-0","article-title":"Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study.","volume":"378","author":"Musallam","year":"2011","journal-title":"Lancet"},{"key":"R5-20260317","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/bjaed\/mkw061","article-title":"Patient blood management and perioperative anaemia.","volume":"17","author":"Thakrar","year":"2016","journal-title":"BJA Educ"},{"key":"R6-20260317","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion reactions: prevention, diagnosis, and treatment.","volume":"388","author":"Delaney","year":"2016","journal-title":"Lancet"},{"key":"R7-20260317","first-page":"112","article-title":"Hazards of blood transfusion in adults and children.","volume":"14","author":"Clevenger","year":"2014","journal-title":"Cont Educ Anaesth Crit Care Pain"},{"key":"R8-20260317","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/jlts.2003.50204","article-title":"Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them.","volume":"9","author":"Ramos","year":"2003","journal-title":"Liver Transpl"},{"issue":"suppl 4","key":"R9-20260317","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1053\/j.jvca.2004.05.004","article-title":"Blood conservation in liver transplantation: the role of aprotinin.","volume":"18","author":"Porte","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R10-20260317","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"R11-20260317","first-page":"281","article-title":"Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.","volume":"85","author":"Kaspar","year":"1997","journal-title":"Anesth Analg"},{"key":"R12-20260317","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/00000542-199611000-00012","article-title":"Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation.","volume":"85","author":"Boylan","year":"1996","journal-title":"Anesthesiology"},{"key":"R13-20260317","first-page":"29","article-title":"Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.","volume":"91","author":"Dalmau","year":"2000","journal-title":"Anesth Analg"},{"key":"R14-20260317","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","article-title":"Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.","volume":"7","author":"Molenaar","year":"2007","journal-title":"Am J Transplant"},{"key":"R15-20260317","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2007-994045","article-title":"Effect of aprotinin on coagulation parameters in liver transplantation.","volume":"19","author":"Welte","year":"1993","journal-title":"Semin Thromb Hemost"},{"key":"R16-20260317","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/75.6.747","article-title":"Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation.","volume":"75","author":"Milroy","year":"1995","journal-title":"Br J Anaesth"},{"key":"R17-20260317","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1213\/00000539-199606000-00004","article-title":"Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation.","volume":"82","author":"Marcel","year":"1996","journal-title":"Anesth Analg"},{"key":"R18-20260317","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.510260509","article-title":"The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.","volume":"26","author":"Garc\u00eda-Huete","year":"1997","journal-title":"Hepatology"},{"key":"R19-20260317","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(00)02111-5","article-title":"Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study EMSALT study group.","volume":"355","author":"Porte","year":"2000","journal-title":"Lancet"},{"key":"R20-20260317","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016.","volume":"34","author":"Kozek-Langenecker","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"R21-20260317","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/TP.0000000000001682","article-title":"The effectiveness and safety of tranexamic acid in orthotopic liver transplantation clinical practice: a propensity score matched cohort study.","volume":"101","author":"Badenoch","year":"2017","journal-title":"Transplantation"},{"key":"R22-20260317","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","article-title":"Tranexamic acid: a clinical review.","volume":"47","author":"Ng","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"key":"R23-20260317","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamasurg.2017.3821","article-title":"Evaluation of military use of tranexamic acid and associated thromboembolic events.","volume":"153","author":"Johnston","year":"2018","journal-title":"JAMA Surg"},{"key":"R24-20260317","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism.","volume":"86","author":"Myers","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R25-20260317","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MBC.0000000000000733","article-title":"Incidence and clinical significance of hyperfibrinolysis during living donor liver transplantation.","volume":"29","author":"Kim","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R26-20260317","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s11605-008-0753-y","article-title":"Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation.","volume":"13","author":"M\u00fcller","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"R27-20260317","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R28-20260317","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/lt.21705","article-title":"A single-center experience of 500 liver transplants using the modified piggyback technique by Belghiti.","volume":"15","author":"Mehrabi","year":"2009","journal-title":"Liver Transpl"},{"key":"R29-20260317","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-Value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"R30-20260317","doi-asserted-by":"crossref","first-page":"1043674","DOI":"10.3389\/fmed.2022.1043674","article-title":"Perioperative prothrombin complex concentrate and fibrinogen administration are associated with thrombotic complications after liver transplant.","volume":"9","author":"Dehne","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R31-20260317","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s40140-018-0270-9","article-title":"Liver Transplantation: perioperative care and update on intraoperative management.","volume":"8","author":"Herborn","year":"2018","journal-title":"Curr Anesthesiol Rep"},{"key":"R32-20260317","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1345\/aph.1Q726","article-title":"Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.","volume":"46","author":"Pincus","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R33-20260317","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1538-7836.2008.02831.x","article-title":"Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review.","volume":"6","author":"Warnaar","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R34-20260317","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"R35-20260317","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000542-199708000-00033","article-title":"Fatal pulmonary embolism during liver transplantation.","volume":"87","author":"Sopher","year":"1997","journal-title":"Anesthesiology"},{"key":"R36-20260317","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1213\/00000539-200008000-00009","article-title":"Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options.","volume":"91","author":"O\u2019Connor","year":"2000","journal-title":"Anesth Analg"},{"key":"R37-20260317","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/lt.20064","article-title":"Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated?","volume":"10","author":"Ramsay","year":"2004","journal-title":"Liver Transpl"},{"key":"R38-20260317","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2015.10.043","article-title":"Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit.","volume":"150","author":"Su","year":"2016","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"R39-20260317","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13197","article-title":"OPTN\/SRTR 2013 annual data report: liver.","volume":"15","author":"Kim","year":"2015","journal-title":"Am J Transplant"},{"key":"R40-20260317","doi-asserted-by":"crossref","first-page":"100585","DOI":"10.1016\/j.trre.2020.100585","article-title":"Organ donation in the US and Europe: the supply vs demand imbalance.","volume":"35","author":"Lewis","year":"2021","journal-title":"Transplant Rev (Orlando)"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:15:21Z","timestamp":1786112121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006804","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}